Array Technologies, Inc. - Common Stock (ARRY)
$6.74
0.15 (2.20%)
ARRY Stock Quote Delayed 30 Minutes
ARRY Stock: Why Solar Play Array Technologies Is Plunging 30% Today
ARRY stock is getting slammed after management disappointed investors with first-quarter results and its failure to confirm or update full-year guidance.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
855.31M
PE Ratio
-6.94
EPS
-0.97
Volume (Avg. Vol.)
2.68M
Day's Range
$6.63 - $6.89
52-Week Range
$5.15 - $15.25
Dividend & Yield
N/A (N/A)
ARRY Stock Predictions, Articles, and Array Technologies, Inc. - Common Stock News
Now’s the Time for Caution When it Comes to Array Technologies
There are many reasons to believe that Array Technologies stock will be a strong renewable energy investment. That may be-- but maybe not right now.
Accounting Misdirection Could Send Array Technologies Stock Falling 50%
Array Technologies stock will drop 50% unless the company can extend innovation from its accounting department to its engineering one.
Should Oaktree Capital Sell the Rest of Its Array Technologies Stock?
Oaktree Capital did well investing in Array Technologies stock. Should it sell after the 180-day lock-up or wait for ARRY to move higher?
Understand the Risks Before Buying Array Technologies Stock
Thanks to solar sentiment, Array Technologies stock is an interesting play. However, be aware of its distinct risk profile before you invest.
There’s No Need to Rush Into Array Technologies Stock Just Yet
Array Technologies stock offers an attractive long-term play on solar growth. But investors should look for a better entry point down the line.
Prepare for a Good Opportunity to Go Long Array Technologies Stock
Array Technologies stock is likely to become a long-term winner as the future looks bright for shareholders
Array Technologies Is Hard to Resist, but Waiting Is the Right Thing to Do
Solar market investors might want to gobble up shares of red-hot Array Technologies stock, but you need to time your entry correctly.
Wait for a Post-Election Pullback to Buy Array Technologies Stock
Array Technologies stock may be red hot, but investors should wait this one out. Valuation and election concerns make it a bit risky here.
Wait for a Pullback to Buy Solar IPO Array Technologies Stock
Solar play Array Technologies stock is on my watch list, but it's too new to jump in right now. Wait for a pullback.
Array Technologies Stock Is an IPO Winner, but Flex Stock Is a Better Buy
Array Technologies is an IPO winner, even though it's low technology. Buy Flex stock instead of Array Technologies stock, since it is likely to spin off or carve out its Nextracker division.
ARRY IPO: 7 Things for Array Technologies Stock Investors to Know
As solar play ARRY gets ready to debut on the public markets, here is what you need to know about the Array Technologies IPO.
Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal
Array BioPharma news for Monday concerning a deal with Pfizer (PFE) that will have the two companies coming together has ARRY stock soaring.
3 Big Stock Charts for Wednesday: Oracle, Lamb Weston Holdings and TJX Companies
The stock charts of TJX, LW and ORCL are on the brink of big moves as we move into the middle of the trading week.
3 Big Stock Charts for Wednesday: Amazon.com, Inc. (AMZN), Array Biopharma Inc (ARRY) and Paychex, Inc. (PAYX)
Amazon (AMZN), Array Biopharma (ARRY) and Paychex (PAYX) are sending clear signs that traders will be using to position themselves for the next 5-10% move in each name.
13 Biotechnology Stocks to Buy Now
This week, 13 Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
